nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—lung cancer	0.53	1	CbGaD
Risedronate—PTGS2—Cisplatin—lung cancer	0.0686	0.504	CbGbCtD
Risedronate—PTGS2—Etoposide—lung cancer	0.0674	0.496	CbGbCtD
Risedronate—FDPS—respiratory system—lung cancer	0.00182	0.151	CbGeAlD
Risedronate—FDPS—bronchus—lung cancer	0.0015	0.125	CbGeAlD
Risedronate—FDPS—trachea—lung cancer	0.00135	0.112	CbGeAlD
Risedronate—FDPS—cardiac atrium—lung cancer	0.00126	0.105	CbGeAlD
Risedronate—FDPS—bone marrow—lung cancer	0.00107	0.0887	CbGeAlD
Risedronate—FDPS—lung—lung cancer	0.000967	0.0804	CbGeAlD
Risedronate—PTGS2—respiratory system—lung cancer	0.000698	0.058	CbGeAlD
Risedronate—FDPS—lymph node—lung cancer	0.000661	0.055	CbGeAlD
Risedronate—PTGS2—epithelium—lung cancer	0.000583	0.0485	CbGeAlD
Risedronate—PTGS2—bronchus—lung cancer	0.000574	0.0477	CbGeAlD
Risedronate—PTGS2—trachea—lung cancer	0.000516	0.0429	CbGeAlD
Risedronate—PTGS2—bone marrow—lung cancer	0.000409	0.034	CbGeAlD
Risedronate—PTGS2—lung—lung cancer	0.000371	0.0308	CbGeAlD
Risedronate—PTGS2—lymph node—lung cancer	0.000253	0.0211	CbGeAlD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—RAF1—lung cancer	0.000168	0.00363	CbGpPWpGaD
Risedronate—Infection—Paclitaxel—lung cancer	0.000162	0.000588	CcSEcCtD
Risedronate—Dyspnoea—Cisplatin—lung cancer	0.000162	0.000588	CcSEcCtD
Risedronate—Skin disorder—Etoposide—lung cancer	0.000162	0.000587	CcSEcCtD
Risedronate—FDPS—Metabolism—B4GALT5—lung cancer	0.000161	0.00347	CbGpPWpGaD
Risedronate—Shock—Paclitaxel—lung cancer	0.000161	0.000583	CcSEcCtD
Risedronate—Dizziness—Vinorelbine—lung cancer	0.00016	0.000582	CcSEcCtD
Risedronate—Abdominal pain upper—Doxorubicin—lung cancer	0.00016	0.000582	CcSEcCtD
Risedronate—Nervous system disorder—Paclitaxel—lung cancer	0.00016	0.000581	CcSEcCtD
Risedronate—Breast disorder—Doxorubicin—lung cancer	0.000159	0.000576	CcSEcCtD
Risedronate—Skin disorder—Paclitaxel—lung cancer	0.000159	0.000575	CcSEcCtD
Risedronate—Abdominal pain—Irinotecan—lung cancer	0.000158	0.000574	CcSEcCtD
Risedronate—Body temperature increased—Irinotecan—lung cancer	0.000158	0.000574	CcSEcCtD
Risedronate—Pneumonia—Methotrexate—lung cancer	0.000157	0.00057	CcSEcCtD
Risedronate—Nasopharyngitis—Doxorubicin—lung cancer	0.000157	0.00057	CcSEcCtD
Risedronate—Gastrointestinal disorder—Cisplatin—lung cancer	0.000157	0.000569	CcSEcCtD
Risedronate—Anaemia—Docetaxel—lung cancer	0.000157	0.000568	CcSEcCtD
Risedronate—Infestation NOS—Methotrexate—lung cancer	0.000156	0.000567	CcSEcCtD
Risedronate—Infestation—Methotrexate—lung cancer	0.000156	0.000567	CcSEcCtD
Risedronate—FDPS—Metabolism—GSTA4—lung cancer	0.000156	0.00338	CbGpPWpGaD
Risedronate—Depression—Methotrexate—lung cancer	0.000156	0.000565	CcSEcCtD
Risedronate—Gastritis—Doxorubicin—lung cancer	0.000155	0.000564	CcSEcCtD
Risedronate—Pain—Cisplatin—lung cancer	0.000155	0.000564	CcSEcCtD
Risedronate—Muscular weakness—Doxorubicin—lung cancer	0.000155	0.000562	CcSEcCtD
Risedronate—Vomiting—Vinorelbine—lung cancer	0.000154	0.00056	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—FOXO3—lung cancer	0.000154	0.00333	CbGpPWpGaD
Risedronate—Body temperature increased—Gemcitabine—lung cancer	0.000154	0.000559	CcSEcCtD
Risedronate—Rash—Vinorelbine—lung cancer	0.000153	0.000555	CcSEcCtD
Risedronate—Dermatitis—Vinorelbine—lung cancer	0.000153	0.000555	CcSEcCtD
Risedronate—Abdominal distension—Doxorubicin—lung cancer	0.000153	0.000554	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000153	0.0033	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTA2—lung cancer	0.000152	0.00329	CbGpPWpGaD
Risedronate—Headache—Vinorelbine—lung cancer	0.000152	0.000551	CcSEcCtD
Risedronate—Syncope—Docetaxel—lung cancer	0.000152	0.000551	CcSEcCtD
Risedronate—Conjunctivitis—Methotrexate—lung cancer	0.000152	0.000551	CcSEcCtD
Risedronate—Asthma—Doxorubicin—lung cancer	0.000152	0.000551	CcSEcCtD
Risedronate—Influenza—Doxorubicin—lung cancer	0.000152	0.000551	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	0.00015	0.00323	CbGpPWpGaD
Risedronate—Paraesthesia—Etoposide—lung cancer	0.000149	0.000542	CcSEcCtD
Risedronate—Loss of consciousness—Docetaxel—lung cancer	0.000149	0.00054	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000149	0.000539	CcSEcCtD
Risedronate—Dyspnoea—Etoposide—lung cancer	0.000148	0.000538	CcSEcCtD
Risedronate—Cough—Docetaxel—lung cancer	0.000148	0.000537	CcSEcCtD
Risedronate—Angina pectoris—Doxorubicin—lung cancer	0.000148	0.000537	CcSEcCtD
Risedronate—Hepatobiliary disease—Methotrexate—lung cancer	0.000148	0.000536	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—lung cancer	0.000148	0.00319	CbGpPWpGaD
Risedronate—Insomnia—Paclitaxel—lung cancer	0.000148	0.000536	CcSEcCtD
Risedronate—Hypersensitivity—Irinotecan—lung cancer	0.000147	0.000535	CcSEcCtD
Risedronate—FDPS—Metabolism—GSTA1—lung cancer	0.000147	0.00317	CbGpPWpGaD
Risedronate—Paraesthesia—Paclitaxel—lung cancer	0.000147	0.000532	CcSEcCtD
Risedronate—Hypertension—Docetaxel—lung cancer	0.000146	0.000531	CcSEcCtD
Risedronate—Bronchitis—Doxorubicin—lung cancer	0.000146	0.00053	CcSEcCtD
Risedronate—Dyspnoea—Paclitaxel—lung cancer	0.000145	0.000528	CcSEcCtD
Risedronate—FDPS—Metabolism—ABCC3—lung cancer	0.000145	0.00314	CbGpPWpGaD
Risedronate—Myalgia—Docetaxel—lung cancer	0.000144	0.000524	CcSEcCtD
Risedronate—Arthralgia—Docetaxel—lung cancer	0.000144	0.000524	CcSEcCtD
Risedronate—Chest pain—Docetaxel—lung cancer	0.000144	0.000524	CcSEcCtD
Risedronate—Nausea—Vinorelbine—lung cancer	0.000144	0.000523	CcSEcCtD
Risedronate—Gastrointestinal disorder—Etoposide—lung cancer	0.000144	0.000521	CcSEcCtD
Risedronate—Dyspepsia—Paclitaxel—lung cancer	0.000144	0.000521	CcSEcCtD
Risedronate—Body temperature increased—Cisplatin—lung cancer	0.000144	0.000521	CcSEcCtD
Risedronate—Asthenia—Irinotecan—lung cancer	0.000144	0.000521	CcSEcCtD
Risedronate—Fatigue—Etoposide—lung cancer	0.000143	0.000521	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000143	0.00052	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000143	0.00308	CbGpPWpGaD
Risedronate—Constipation—Etoposide—lung cancer	0.000142	0.000516	CcSEcCtD
Risedronate—Pain—Etoposide—lung cancer	0.000142	0.000516	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	0.000142	0.00307	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—lung cancer	0.000141	0.00305	CbGpPWpGaD
Risedronate—Dry mouth—Docetaxel—lung cancer	0.000141	0.000512	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—lung cancer	0.000141	0.00305	CbGpPWpGaD
Risedronate—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000141	0.000512	CcSEcCtD
Risedronate—Haemoglobin—Methotrexate—lung cancer	0.000141	0.000512	CcSEcCtD
Risedronate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000141	0.000511	CcSEcCtD
Risedronate—FDPS—Metabolism—AKR1C1—lung cancer	0.000141	0.00304	CbGpPWpGaD
Risedronate—Fatigue—Paclitaxel—lung cancer	0.000141	0.00051	CcSEcCtD
Risedronate—Haemorrhage—Methotrexate—lung cancer	0.00014	0.000509	CcSEcCtD
Risedronate—Asthenia—Gemcitabine—lung cancer	0.00014	0.000507	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—APOA1—lung cancer	0.00014	0.00302	CbGpPWpGaD
Risedronate—Pain—Paclitaxel—lung cancer	0.00014	0.000506	CcSEcCtD
Risedronate—Constipation—Paclitaxel—lung cancer	0.00014	0.000506	CcSEcCtD
Risedronate—Pharyngitis—Methotrexate—lung cancer	0.000139	0.000505	CcSEcCtD
Risedronate—Urinary tract disorder—Methotrexate—lung cancer	0.000139	0.000503	CcSEcCtD
Risedronate—Pruritus—Gemcitabine—lung cancer	0.000138	0.0005	CcSEcCtD
Risedronate—Urethral disorder—Methotrexate—lung cancer	0.000138	0.000499	CcSEcCtD
Risedronate—Infection—Docetaxel—lung cancer	0.000137	0.000499	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—lung cancer	0.000137	0.00296	CbGpPWpGaD
Risedronate—Diarrhoea—Irinotecan—lung cancer	0.000137	0.000497	CcSEcCtD
Risedronate—FDPS—Metabolism—UGT1A1—lung cancer	0.000137	0.00295	CbGpPWpGaD
Risedronate—Pneumonia—Doxorubicin—lung cancer	0.000136	0.000494	CcSEcCtD
Risedronate—Gastrointestinal pain—Etoposide—lung cancer	0.000136	0.000494	CcSEcCtD
Risedronate—Shock—Docetaxel—lung cancer	0.000136	0.000494	CcSEcCtD
Risedronate—Nervous system disorder—Docetaxel—lung cancer	0.000136	0.000492	CcSEcCtD
Risedronate—Infestation NOS—Doxorubicin—lung cancer	0.000135	0.000491	CcSEcCtD
Risedronate—Infestation—Doxorubicin—lung cancer	0.000135	0.000491	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—EP300—lung cancer	0.000135	0.00292	CbGpPWpGaD
Risedronate—Skin disorder—Docetaxel—lung cancer	0.000134	0.000487	CcSEcCtD
Risedronate—Hypersensitivity—Cisplatin—lung cancer	0.000134	0.000486	CcSEcCtD
Risedronate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000133	0.000484	CcSEcCtD
Risedronate—Diarrhoea—Gemcitabine—lung cancer	0.000133	0.000484	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	0.000133	0.00288	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—KIT—lung cancer	0.000132	0.00286	CbGpPWpGaD
Risedronate—Dizziness—Irinotecan—lung cancer	0.000132	0.00048	CcSEcCtD
Risedronate—Urticaria—Etoposide—lung cancer	0.000132	0.00048	CcSEcCtD
Risedronate—FDPS—Metabolism—GNG11—lung cancer	0.000132	0.00284	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—SRC—lung cancer	0.000132	0.00284	CbGpPWpGaD
Risedronate—Body temperature increased—Etoposide—lung cancer	0.000132	0.000477	CcSEcCtD
Risedronate—Abdominal pain—Etoposide—lung cancer	0.000132	0.000477	CcSEcCtD
Risedronate—Conjunctivitis—Doxorubicin—lung cancer	0.000132	0.000477	CcSEcCtD
Risedronate—Urinary tract infection—Doxorubicin—lung cancer	0.000132	0.000477	CcSEcCtD
Risedronate—Eye disorder—Methotrexate—lung cancer	0.000131	0.000476	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000131	0.00283	CbGpPWpGaD
Risedronate—Tinnitus—Methotrexate—lung cancer	0.000131	0.000475	CcSEcCtD
Risedronate—Asthenia—Cisplatin—lung cancer	0.00013	0.000473	CcSEcCtD
Risedronate—Cardiac disorder—Methotrexate—lung cancer	0.00013	0.000472	CcSEcCtD
Risedronate—Urticaria—Paclitaxel—lung cancer	0.00013	0.00047	CcSEcCtD
Risedronate—Abdominal pain—Paclitaxel—lung cancer	0.000129	0.000468	CcSEcCtD
Risedronate—Body temperature increased—Paclitaxel—lung cancer	0.000129	0.000468	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	0.000128	0.00277	CbGpPWpGaD
Risedronate—Hepatobiliary disease—Doxorubicin—lung cancer	0.000128	0.000464	CcSEcCtD
Risedronate—Angiopathy—Methotrexate—lung cancer	0.000127	0.000462	CcSEcCtD
Risedronate—Vomiting—Irinotecan—lung cancer	0.000127	0.000462	CcSEcCtD
Risedronate—Sinusitis—Doxorubicin—lung cancer	0.000127	0.000461	CcSEcCtD
Risedronate—Immune system disorder—Methotrexate—lung cancer	0.000127	0.00046	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	0.000127	0.00273	CbGpPWpGaD
Risedronate—Mediastinal disorder—Methotrexate—lung cancer	0.000126	0.000459	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—APP—lung cancer	0.000126	0.00273	CbGpPWpGaD
Risedronate—Rash—Irinotecan—lung cancer	0.000126	0.000458	CcSEcCtD
Risedronate—Dermatitis—Irinotecan—lung cancer	0.000126	0.000457	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000126	0.000457	CcSEcCtD
Risedronate—FDPS—Metabolism—ALDOA—lung cancer	0.000125	0.00271	CbGpPWpGaD
Risedronate—Headache—Irinotecan—lung cancer	0.000125	0.000455	CcSEcCtD
Risedronate—Insomnia—Docetaxel—lung cancer	0.000125	0.000454	CcSEcCtD
Risedronate—Diarrhoea—Cisplatin—lung cancer	0.000124	0.000451	CcSEcCtD
Risedronate—Paraesthesia—Docetaxel—lung cancer	0.000124	0.000451	CcSEcCtD
Risedronate—Vomiting—Gemcitabine—lung cancer	0.000124	0.00045	CcSEcCtD
Risedronate—Dyspnoea—Docetaxel—lung cancer	0.000123	0.000447	CcSEcCtD
Risedronate—Mental disorder—Methotrexate—lung cancer	0.000123	0.000446	CcSEcCtD
Risedronate—Rash—Gemcitabine—lung cancer	0.000123	0.000446	CcSEcCtD
Risedronate—Dermatitis—Gemcitabine—lung cancer	0.000123	0.000445	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—CREBBP—lung cancer	0.000123	0.00265	CbGpPWpGaD
Risedronate—Hypersensitivity—Etoposide—lung cancer	0.000123	0.000445	CcSEcCtD
Risedronate—Malnutrition—Methotrexate—lung cancer	0.000122	0.000443	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—lung cancer	0.000122	0.000443	CcSEcCtD
Risedronate—Headache—Gemcitabine—lung cancer	0.000122	0.000443	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—lung cancer	0.000122	0.000442	CcSEcCtD
Risedronate—Dyspepsia—Docetaxel—lung cancer	0.000122	0.000442	CcSEcCtD
Risedronate—FDPS—Metabolism—NCOA3—lung cancer	0.000122	0.00263	CbGpPWpGaD
Risedronate—Haemorrhage—Doxorubicin—lung cancer	0.000122	0.000441	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—lung cancer	0.000121	0.000438	CcSEcCtD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—lung cancer	0.000121	0.0026	CbGpPWpGaD
Risedronate—Hypersensitivity—Paclitaxel—lung cancer	0.00012	0.000436	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—lung cancer	0.00012	0.000435	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—lung cancer	0.00012	0.000434	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	0.00012	0.00259	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.00012	0.00258	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Docetaxel—lung cancer	0.000119	0.000433	CcSEcCtD
Risedronate—Asthenia—Etoposide—lung cancer	0.000119	0.000433	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—lung cancer	0.000119	0.000433	CcSEcCtD
Risedronate—Fatigue—Docetaxel—lung cancer	0.000119	0.000433	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—lung cancer	0.000119	0.000432	CcSEcCtD
Risedronate—Nausea—Irinotecan—lung cancer	0.000119	0.000431	CcSEcCtD
Risedronate—FDPS—Metabolism—ADCY1—lung cancer	0.000118	0.00256	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCG2—lung cancer	0.000118	0.00256	CbGpPWpGaD
Risedronate—Constipation—Docetaxel—lung cancer	0.000118	0.000429	CcSEcCtD
Risedronate—Pain—Docetaxel—lung cancer	0.000118	0.000429	CcSEcCtD
Risedronate—Back pain—Methotrexate—lung cancer	0.000118	0.000429	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—MYC—lung cancer	0.000118	0.00255	CbGpPWpGaD
Risedronate—Pruritus—Etoposide—lung cancer	0.000118	0.000427	CcSEcCtD
Risedronate—Asthenia—Paclitaxel—lung cancer	0.000117	0.000425	CcSEcCtD
Risedronate—FDPS—Metabolism—ENO2—lung cancer	0.000116	0.00251	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HPGDS—lung cancer	0.000116	0.00251	CbGpPWpGaD
Risedronate—Nausea—Gemcitabine—lung cancer	0.000116	0.00042	CcSEcCtD
Risedronate—Vomiting—Cisplatin—lung cancer	0.000116	0.000419	CcSEcCtD
Risedronate—Pruritus—Paclitaxel—lung cancer	0.000115	0.000419	CcSEcCtD
Risedronate—FDPS—Metabolism—PPP2R1B—lung cancer	0.000115	0.00249	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	0.000115	0.00249	CbGpPWpGaD
Risedronate—Rash—Cisplatin—lung cancer	0.000115	0.000416	CcSEcCtD
Risedronate—Dermatitis—Cisplatin—lung cancer	0.000114	0.000415	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.000114	0.00246	CbGpPWpGaD
Risedronate—Diarrhoea—Etoposide—lung cancer	0.000114	0.000413	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—lung cancer	0.000114	0.000412	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—lung cancer	0.000113	0.000411	CcSEcCtD
Risedronate—Gastrointestinal pain—Docetaxel—lung cancer	0.000113	0.00041	CcSEcCtD
Risedronate—Anaemia—Methotrexate—lung cancer	0.000113	0.00041	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—lung cancer	0.000113	0.000409	CcSEcCtD
Risedronate—FDPS—Metabolism—GSTT1—lung cancer	0.000113	0.00243	CbGpPWpGaD
Risedronate—Diarrhoea—Paclitaxel—lung cancer	0.000112	0.000405	CcSEcCtD
Risedronate—FDPS—Metabolism—CYP2A6—lung cancer	0.000111	0.00241	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GCLC—lung cancer	0.000111	0.00241	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000111	0.0024	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000111	0.0024	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ALB—lung cancer	0.000111	0.00239	CbGpPWpGaD
Risedronate—Angiopathy—Doxorubicin—lung cancer	0.00011	0.0004	CcSEcCtD
Risedronate—Dizziness—Etoposide—lung cancer	0.00011	0.000399	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—lung cancer	0.00011	0.000398	CcSEcCtD
Risedronate—Vertigo—Methotrexate—lung cancer	0.00011	0.000398	CcSEcCtD
Risedronate—Mediastinal disorder—Doxorubicin—lung cancer	0.00011	0.000397	CcSEcCtD
Risedronate—Body temperature increased—Docetaxel—lung cancer	0.000109	0.000397	CcSEcCtD
Risedronate—Abdominal pain—Docetaxel—lung cancer	0.000109	0.000397	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	0.000109	0.00235	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000109	0.00235	CbGpPWpGaD
Risedronate—Arrhythmia—Doxorubicin—lung cancer	0.000109	0.000394	CcSEcCtD
Risedronate—Dizziness—Paclitaxel—lung cancer	0.000108	0.000392	CcSEcCtD
Risedronate—Nausea—Cisplatin—lung cancer	0.000108	0.000392	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN2A—lung cancer	0.000107	0.00232	CbGpPWpGaD
Risedronate—Cough—Methotrexate—lung cancer	0.000107	0.000387	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—lung cancer	0.000106	0.000386	CcSEcCtD
Risedronate—Vomiting—Etoposide—lung cancer	0.000106	0.000384	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—lung cancer	0.000106	0.000384	CcSEcCtD
Risedronate—FDPS—Metabolism—ENO1—lung cancer	0.000106	0.00228	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000105	0.00227	CbGpPWpGaD
Risedronate—Rash—Etoposide—lung cancer	0.000105	0.000381	CcSEcCtD
Risedronate—Dermatitis—Etoposide—lung cancer	0.000105	0.00038	CcSEcCtD
Risedronate—Headache—Etoposide—lung cancer	0.000104	0.000378	CcSEcCtD
Risedronate—Flatulence—Doxorubicin—lung cancer	0.000104	0.000378	CcSEcCtD
Risedronate—Chest pain—Methotrexate—lung cancer	0.000104	0.000377	CcSEcCtD
Risedronate—Arthralgia—Methotrexate—lung cancer	0.000104	0.000377	CcSEcCtD
Risedronate—Myalgia—Methotrexate—lung cancer	0.000104	0.000377	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.000104	0.00224	CbGpPWpGaD
Risedronate—Vomiting—Paclitaxel—lung cancer	0.000104	0.000376	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000103	0.000375	CcSEcCtD
Risedronate—Rash—Paclitaxel—lung cancer	0.000103	0.000373	CcSEcCtD
Risedronate—Dermatitis—Paclitaxel—lung cancer	0.000103	0.000373	CcSEcCtD
Risedronate—Back pain—Doxorubicin—lung cancer	0.000102	0.000371	CcSEcCtD
Risedronate—Headache—Paclitaxel—lung cancer	0.000102	0.000371	CcSEcCtD
Risedronate—Hypersensitivity—Docetaxel—lung cancer	0.000102	0.00037	CcSEcCtD
Risedronate—Muscle spasms—Doxorubicin—lung cancer	0.000102	0.000369	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—CD4—lung cancer	0.000101	0.00219	CbGpPWpGaD
Risedronate—Asthenia—Docetaxel—lung cancer	9.92e-05	0.00036	CcSEcCtD
Risedronate—Infection—Methotrexate—lung cancer	9.9e-05	0.000359	CcSEcCtD
Risedronate—Nausea—Etoposide—lung cancer	9.89e-05	0.000359	CcSEcCtD
Risedronate—Pruritus—Docetaxel—lung cancer	9.79e-05	0.000355	CcSEcCtD
Risedronate—Nervous system disorder—Methotrexate—lung cancer	9.78e-05	0.000355	CcSEcCtD
Risedronate—Anaemia—Doxorubicin—lung cancer	9.78e-05	0.000355	CcSEcCtD
Risedronate—Nausea—Paclitaxel—lung cancer	9.69e-05	0.000352	CcSEcCtD
Risedronate—Skin disorder—Methotrexate—lung cancer	9.68e-05	0.000351	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	9.52e-05	0.00206	CbGpPWpGaD
Risedronate—Vertigo—Doxorubicin—lung cancer	9.5e-05	0.000345	CcSEcCtD
Risedronate—Syncope—Doxorubicin—lung cancer	9.49e-05	0.000344	CcSEcCtD
Risedronate—FDPS—Metabolism—CYP2E1—lung cancer	9.47e-05	0.00205	CbGpPWpGaD
Risedronate—Diarrhoea—Docetaxel—lung cancer	9.46e-05	0.000343	CcSEcCtD
Risedronate—FDPS—Metabolism—NQO1—lung cancer	9.36e-05	0.00202	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	9.35e-05	0.00202	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—RB1—lung cancer	9.32e-05	0.00201	CbGpPWpGaD
Risedronate—Loss of consciousness—Doxorubicin—lung cancer	9.3e-05	0.000337	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	9.26e-05	0.002	CbGpPWpGaD
Risedronate—Cough—Doxorubicin—lung cancer	9.23e-05	0.000335	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.17e-05	0.00198	CbGpPWpGaD
Risedronate—Dizziness—Docetaxel—lung cancer	9.15e-05	0.000332	CcSEcCtD
Risedronate—Hypertension—Doxorubicin—lung cancer	9.13e-05	0.000331	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.08e-05	0.00196	CbGpPWpGaD
Risedronate—Musculoskeletal discomfort—Methotrexate—lung cancer	9.08e-05	0.00033	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—CCND1—lung cancer	9.08e-05	0.00196	CbGpPWpGaD
Risedronate—Insomnia—Methotrexate—lung cancer	9.02e-05	0.000327	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—lung cancer	9e-05	0.000327	CcSEcCtD
Risedronate—Chest pain—Doxorubicin—lung cancer	9e-05	0.000327	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—lung cancer	9e-05	0.000327	CcSEcCtD
Risedronate—Anxiety—Doxorubicin—lung cancer	8.97e-05	0.000326	CcSEcCtD
Risedronate—Paraesthesia—Methotrexate—lung cancer	8.95e-05	0.000325	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.94e-05	0.000324	CcSEcCtD
Risedronate—Dyspnoea—Methotrexate—lung cancer	8.89e-05	0.000322	CcSEcCtD
Risedronate—Dry mouth—Doxorubicin—lung cancer	8.81e-05	0.00032	CcSEcCtD
Risedronate—Vomiting—Docetaxel—lung cancer	8.79e-05	0.000319	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN1A—lung cancer	8.79e-05	0.0019	CbGpPWpGaD
Risedronate—Dyspepsia—Methotrexate—lung cancer	8.78e-05	0.000318	CcSEcCtD
Risedronate—Rash—Docetaxel—lung cancer	8.72e-05	0.000316	CcSEcCtD
Risedronate—Dermatitis—Docetaxel—lung cancer	8.71e-05	0.000316	CcSEcCtD
Risedronate—Headache—Docetaxel—lung cancer	8.67e-05	0.000314	CcSEcCtD
Risedronate—Gastrointestinal disorder—Methotrexate—lung cancer	8.61e-05	0.000312	CcSEcCtD
Risedronate—Fatigue—Methotrexate—lung cancer	8.6e-05	0.000312	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	8.59e-05	0.00186	CbGpPWpGaD
Risedronate—Infection—Doxorubicin—lung cancer	8.58e-05	0.000311	CcSEcCtD
Risedronate—Pain—Methotrexate—lung cancer	8.53e-05	0.000309	CcSEcCtD
Risedronate—Shock—Doxorubicin—lung cancer	8.49e-05	0.000308	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—lung cancer	8.47e-05	0.000307	CcSEcCtD
Risedronate—FDPS—Metabolism—STK11—lung cancer	8.44e-05	0.00182	CbGpPWpGaD
Risedronate—Skin disorder—Doxorubicin—lung cancer	8.38e-05	0.000304	CcSEcCtD
Risedronate—PTGS2—Metabolism—COL4A3BP—lung cancer	8.38e-05	0.00181	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AZIN2—lung cancer	8.38e-05	0.00181	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—EP300—lung cancer	8.36e-05	0.00181	CbGpPWpGaD
Risedronate—Nausea—Docetaxel—lung cancer	8.22e-05	0.000298	CcSEcCtD
Risedronate—Gastrointestinal pain—Methotrexate—lung cancer	8.15e-05	0.000296	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.92e-05	0.00171	CbGpPWpGaD
Risedronate—Urticaria—Methotrexate—lung cancer	7.92e-05	0.000287	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	7.91e-05	0.00171	CbGpPWpGaD
Risedronate—Abdominal pain—Methotrexate—lung cancer	7.88e-05	0.000286	CcSEcCtD
Risedronate—Body temperature increased—Methotrexate—lung cancer	7.88e-05	0.000286	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.86e-05	0.000285	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—NRAS—lung cancer	7.82e-05	0.00169	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	7.81e-05	0.00169	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTP1—lung cancer	7.81e-05	0.00169	CbGpPWpGaD
Risedronate—Insomnia—Doxorubicin—lung cancer	7.81e-05	0.000283	CcSEcCtD
Risedronate—Paraesthesia—Doxorubicin—lung cancer	7.75e-05	0.000281	CcSEcCtD
Risedronate—Dyspnoea—Doxorubicin—lung cancer	7.7e-05	0.000279	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—lung cancer	7.6e-05	0.000276	CcSEcCtD
Risedronate—FDPS—Metabolism—CAT—lung cancer	7.6e-05	0.00164	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	7.57e-05	0.00163	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.55e-05	0.00163	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Doxorubicin—lung cancer	7.45e-05	0.00027	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—lung cancer	7.44e-05	0.00027	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—CXCL8—lung cancer	7.43e-05	0.0016	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCB1—lung cancer	7.39e-05	0.0016	CbGpPWpGaD
Risedronate—Pain—Doxorubicin—lung cancer	7.38e-05	0.000268	CcSEcCtD
Risedronate—Constipation—Doxorubicin—lung cancer	7.38e-05	0.000268	CcSEcCtD
Risedronate—Hypersensitivity—Methotrexate—lung cancer	7.34e-05	0.000266	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—MYC—lung cancer	7.28e-05	0.00157	CbGpPWpGaD
Risedronate—FDPS—Metabolism—TYMS—lung cancer	7.26e-05	0.00157	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTM1—lung cancer	7.18e-05	0.00155	CbGpPWpGaD
Risedronate—Asthenia—Methotrexate—lung cancer	7.15e-05	0.00026	CcSEcCtD
Risedronate—PTGS2—Metabolism—ATP5H—lung cancer	7.13e-05	0.00154	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CASP3—lung cancer	7.11e-05	0.00154	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL2—lung cancer	7.1e-05	0.00153	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Doxorubicin—lung cancer	7.06e-05	0.000256	CcSEcCtD
Risedronate—Pruritus—Methotrexate—lung cancer	7.05e-05	0.000256	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—CCND1—lung cancer	6.92e-05	0.00149	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—APC—lung cancer	6.86e-05	0.00148	CbGpPWpGaD
Risedronate—Urticaria—Doxorubicin—lung cancer	6.86e-05	0.000249	CcSEcCtD
Risedronate—Body temperature increased—Doxorubicin—lung cancer	6.82e-05	0.000248	CcSEcCtD
Risedronate—Abdominal pain—Doxorubicin—lung cancer	6.82e-05	0.000248	CcSEcCtD
Risedronate—Diarrhoea—Methotrexate—lung cancer	6.82e-05	0.000247	CcSEcCtD
Risedronate—FDPS—Metabolism—CYP1A1—lung cancer	6.8e-05	0.00147	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	6.78e-05	0.00147	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ERCC2—lung cancer	6.75e-05	0.00146	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—KRAS—lung cancer	6.73e-05	0.00145	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MMP9—lung cancer	6.72e-05	0.00145	CbGpPWpGaD
Risedronate—Dizziness—Methotrexate—lung cancer	6.59e-05	0.000239	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	6.55e-05	0.00141	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	6.39e-05	0.00138	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	6.36e-05	0.00137	CbGpPWpGaD
Risedronate—Hypersensitivity—Doxorubicin—lung cancer	6.36e-05	0.000231	CcSEcCtD
Risedronate—PTGS2—Metabolism—PLBD1—lung cancer	6.35e-05	0.00137	CbGpPWpGaD
Risedronate—Vomiting—Methotrexate—lung cancer	6.34e-05	0.00023	CcSEcCtD
Risedronate—Rash—Methotrexate—lung cancer	6.29e-05	0.000228	CcSEcCtD
Risedronate—Dermatitis—Methotrexate—lung cancer	6.28e-05	0.000228	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	6.25e-05	0.00135	CbGpPWpGaD
Risedronate—Headache—Methotrexate—lung cancer	6.25e-05	0.000227	CcSEcCtD
Risedronate—Asthenia—Doxorubicin—lung cancer	6.19e-05	0.000225	CcSEcCtD
Risedronate—Pruritus—Doxorubicin—lung cancer	6.11e-05	0.000222	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	6.07e-05	0.00131	CbGpPWpGaD
Risedronate—Nausea—Methotrexate—lung cancer	5.92e-05	0.000215	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—lung cancer	5.91e-05	0.000214	CcSEcCtD
Risedronate—FDPS—Metabolism—APOA1—lung cancer	5.84e-05	0.00126	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSD17B10—lung cancer	5.81e-05	0.00125	CbGpPWpGaD
Risedronate—PTGS2—Disease—PGAM1—lung cancer	5.75e-05	0.00124	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—HRAS—lung cancer	5.72e-05	0.00124	CbGpPWpGaD
Risedronate—Dizziness—Doxorubicin—lung cancer	5.71e-05	0.000207	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—MAPK3—lung cancer	5.71e-05	0.00123	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.59e-05	0.00121	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MYC—lung cancer	5.55e-05	0.0012	CbGpPWpGaD
Risedronate—Vomiting—Doxorubicin—lung cancer	5.49e-05	0.000199	CcSEcCtD
Risedronate—Rash—Doxorubicin—lung cancer	5.44e-05	0.000197	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—lung cancer	5.44e-05	0.000197	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—EGFR—lung cancer	5.43e-05	0.00117	CbGpPWpGaD
Risedronate—Headache—Doxorubicin—lung cancer	5.41e-05	0.000196	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	5.4e-05	0.00117	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CKB—lung cancer	5.4e-05	0.00117	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	5.39e-05	0.00116	CbGpPWpGaD
Risedronate—PTGS2—Disease—SDC4—lung cancer	5.37e-05	0.00116	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	5.33e-05	0.00115	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CG—lung cancer	5.33e-05	0.00115	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—lung cancer	5.28e-05	0.00114	CbGpPWpGaD
Risedronate—Nausea—Doxorubicin—lung cancer	5.13e-05	0.000186	CcSEcCtD
Risedronate—PTGS2—Metabolism—GSTM2—lung cancer	5.08e-05	0.0011	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CNDP2—lung cancer	5.08e-05	0.0011	CbGpPWpGaD
Risedronate—FDPS—Metabolism—POMC—lung cancer	5.07e-05	0.0011	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CREBBP—lung cancer	4.94e-05	0.00107	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTMR3—lung cancer	4.94e-05	0.00107	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	4.84e-05	0.00104	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PGAM1—lung cancer	4.81e-05	0.00104	CbGpPWpGaD
Risedronate—PTGS2—Disease—SKI—lung cancer	4.73e-05	0.00102	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	4.71e-05	0.00102	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	4.7e-05	0.00101	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CD—lung cancer	4.68e-05	0.00101	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALB—lung cancer	4.62e-05	0.000999	CbGpPWpGaD
Risedronate—PTGS2—Disease—B4GALT5—lung cancer	4.59e-05	0.000992	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP2A7—lung cancer	4.59e-05	0.000992	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TP53—lung cancer	4.56e-05	0.000985	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	4.55e-05	0.000984	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	4.54e-05	0.000981	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SDC4—lung cancer	4.49e-05	0.000971	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	4.33e-05	0.000936	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	4.21e-05	0.00091	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—lung cancer	4.17e-05	0.000901	CbGpPWpGaD
Risedronate—PTGS2—Disease—PXN—lung cancer	4.11e-05	0.000888	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	4.1e-05	0.000886	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—RRM1—lung cancer	4.09e-05	0.000884	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTA3—lung cancer	4.09e-05	0.000884	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CB—lung cancer	4.08e-05	0.000882	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—lung cancer	4.05e-05	0.000874	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKR1C1—lung cancer	4.02e-05	0.000869	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.88e-05	0.000839	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—B4GALT5—lung cancer	3.85e-05	0.000831	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	3.78e-05	0.000816	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTA4—lung cancer	3.74e-05	0.000808	CbGpPWpGaD
Risedronate—PTGS2—Disease—NPPA—lung cancer	3.7e-05	0.0008	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.69e-05	0.000798	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.66e-05	0.00079	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTA2—lung cancer	3.65e-05	0.000788	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPIA—lung cancer	3.61e-05	0.000781	CbGpPWpGaD
Risedronate—PTGS2—Disease—ALDOA—lung cancer	3.59e-05	0.000775	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTEN—lung cancer	3.53e-05	0.000762	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTA1—lung cancer	3.52e-05	0.00076	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.49e-05	0.000754	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCC3—lung cancer	3.48e-05	0.000752	CbGpPWpGaD
Risedronate—PTGS2—Disease—ADCY1—lung cancer	3.39e-05	0.000732	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKR1C1—lung cancer	3.37e-05	0.000728	CbGpPWpGaD
Risedronate—FDPS—Metabolism—EP300—lung cancer	3.36e-05	0.000727	CbGpPWpGaD
Risedronate—PTGS2—Disease—ENO2—lung cancer	3.32e-05	0.000717	CbGpPWpGaD
Risedronate—PTGS2—Disease—SMARCA4—lung cancer	3.3e-05	0.000713	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPP2R1B—lung cancer	3.3e-05	0.000713	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—UGT1A1—lung cancer	3.27e-05	0.000707	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.21e-05	0.000692	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GNG11—lung cancer	3.15e-05	0.000681	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.14e-05	0.000678	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	3.1e-05	0.00067	CbGpPWpGaD
Risedronate—PTGS2—Disease—ENO1—lung cancer	3.02e-05	0.000652	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALDOA—lung cancer	3e-05	0.000649	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NCOA3—lung cancer	2.92e-05	0.00063	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.87e-05	0.000619	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ADCY1—lung cancer	2.84e-05	0.000613	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCG2—lung cancer	2.84e-05	0.000613	CbGpPWpGaD
Risedronate—PTGS2—Disease—APP—lung cancer	2.81e-05	0.000606	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF9—lung cancer	2.78e-05	0.000601	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HPGDS—lung cancer	2.78e-05	0.000601	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ENO2—lung cancer	2.78e-05	0.000601	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPP2R1B—lung cancer	2.76e-05	0.000597	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.73e-05	0.000589	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTT1—lung cancer	2.7e-05	0.000583	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GCLC—lung cancer	2.67e-05	0.000576	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP2A6—lung cancer	2.67e-05	0.000576	CbGpPWpGaD
Risedronate—PTGS2—Disease—JUNB—lung cancer	2.66e-05	0.000574	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.66e-05	0.000574	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.62e-05	0.000566	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ENO1—lung cancer	2.53e-05	0.000546	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.52e-05	0.000544	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CA—lung cancer	2.49e-05	0.000538	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.49e-05	0.000537	CbGpPWpGaD
Risedronate—PTGS2—Disease—FOXO3—lung cancer	2.33e-05	0.000503	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP2E1—lung cancer	2.27e-05	0.00049	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NQO1—lung cancer	2.24e-05	0.000484	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.2e-05	0.000474	CbGpPWpGaD
Risedronate—PTGS2—Disease—HES1—lung cancer	2.06e-05	0.000446	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKT1—lung cancer	2.03e-05	0.000439	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—STK11—lung cancer	2.02e-05	0.000437	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERCC2—lung cancer	1.93e-05	0.000417	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.9e-05	0.00041	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERBB3—lung cancer	1.89e-05	0.000408	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTP1—lung cancer	1.87e-05	0.000404	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CAT—lung cancer	1.82e-05	0.000393	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.81e-05	0.000391	CbGpPWpGaD
Risedronate—PTGS2—Disease—TERT—lung cancer	1.81e-05	0.000391	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCB1—lung cancer	1.77e-05	0.000382	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGFR1—lung cancer	1.76e-05	0.000379	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TYMS—lung cancer	1.74e-05	0.000376	CbGpPWpGaD
Risedronate—PTGS2—Disease—HIF1A—lung cancer	1.73e-05	0.000374	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTM1—lung cancer	1.72e-05	0.000371	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOA1—lung cancer	1.67e-05	0.000361	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP1A1—lung cancer	1.63e-05	0.000352	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ERCC2—lung cancer	1.62e-05	0.000349	CbGpPWpGaD
Risedronate—PTGS2—Disease—KIT—lung cancer	1.52e-05	0.000329	CbGpPWpGaD
Risedronate—PTGS2—Disease—APC—lung cancer	1.52e-05	0.000329	CbGpPWpGaD
Risedronate—PTGS2—Disease—EGF—lung cancer	1.51e-05	0.000325	CbGpPWpGaD
Risedronate—PTGS2—Disease—BRAF—lung cancer	1.43e-05	0.000309	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6R—lung cancer	1.41e-05	0.000306	CbGpPWpGaD
Risedronate—PTGS2—Disease—CREBBP—lung cancer	1.41e-05	0.000305	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOA1—lung cancer	1.4e-05	0.000302	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAP2K1—lung cancer	1.35e-05	0.000291	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CD—lung cancer	1.34e-05	0.000289	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.34e-05	0.000289	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CG—lung cancer	1.28e-05	0.000276	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—POMC—lung cancer	1.21e-05	0.000262	CbGpPWpGaD
Risedronate—PTGS2—Disease—MDM2—lung cancer	1.2e-05	0.000259	CbGpPWpGaD
Risedronate—PTGS2—Disease—RAF1—lung cancer	1.2e-05	0.000258	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CREBBP—lung cancer	1.18e-05	0.000256	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERBB2—lung cancer	1.18e-05	0.000256	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CB—lung cancer	1.17e-05	0.000252	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTOR—lung cancer	1.17e-05	0.000252	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD4—lung cancer	1.17e-05	0.000252	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CD—lung cancer	1.12e-05	0.000242	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—lung cancer	1.11e-05	0.000239	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN1A—lung cancer	1.01e-05	0.000218	CbGpPWpGaD
Risedronate—PTGS2—Disease—PTEN—lung cancer	1.01e-05	0.000218	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CB—lung cancer	9.78e-06	0.000211	CbGpPWpGaD
Risedronate—PTGS2—Disease—EP300—lung cancer	9.62e-06	0.000208	CbGpPWpGaD
Risedronate—PTGS2—Disease—SRC—lung cancer	9.36e-06	0.000202	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT3—lung cancer	9.02e-06	0.000195	CbGpPWpGaD
Risedronate—PTGS2—Disease—NRAS—lung cancer	9e-06	0.000194	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAPK3—lung cancer	8.62e-06	0.000186	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTEN—lung cancer	8.45e-06	0.000183	CbGpPWpGaD
Risedronate—PTGS2—Disease—MYC—lung cancer	8.38e-06	0.000181	CbGpPWpGaD
Risedronate—PTGS2—Disease—EGFR—lung cancer	8.2e-06	0.000177	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—EP300—lung cancer	8.06e-06	0.000174	CbGpPWpGaD
Risedronate—PTGS2—Disease—KRAS—lung cancer	7.75e-06	0.000167	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CA—lung cancer	7.12e-06	0.000154	CbGpPWpGaD
Risedronate—PTGS2—Disease—HRAS—lung cancer	6.59e-06	0.000142	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—lung cancer	6.3e-06	0.000136	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CA—lung cancer	5.96e-06	0.000129	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT1—lung cancer	5.81e-06	0.000126	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKT1—lung cancer	4.87e-06	0.000105	CbGpPWpGaD
